Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Irbesartan, sold under the brand name Aprovel among others, is a medication used to treat hypertension (high blood pressure), heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination irbesartan/hydrochlorothiazide.
History, Community, Culture & Applications
Explore the main themes, entities and connections around Irbesartan. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
blood pressure kidney effects combination aprovel hypertension medication available high nitrosamine side hydrochlorothiazide name others mouth may also impurities brand
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Irbesartan | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Irbesartan | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Irbesartan | ATC code | C09CA04 (WHO) C09DA04 (WHO) | 1.00 | infobox |
| Irbesartan | Bioavailability | 60% to 80% | 1.00 | infobox |
| Irbesartan | CAS Number | 138402-11-6 Y | 1.00 | infobox |
| Irbesartan | ChEBI | CHEBI:5959 Y | 1.00 | infobox |
| Irbesartan | ChEMBL | ChEMBL1513 Y | 1.00 | infobox |
| Irbesartan | ChemSpider | 3618 Y | 1.00 | infobox |
| Irbesartan | CompTox Dashboard (EPA) | DTXSID0023169 | 1.00 | infobox |
| Irbesartan | Drug class | Cardiovascular agent | 1.00 | infobox |
| Irbesartan | DrugBank | DB01029 Y | 1.00 | infobox |
| Irbesartan | ECHA InfoCard | 100.119.966 | 1.00 | infobox |
| Irbesartan | Elimination half-life | 11 h to 15 h | 1.00 | infobox |
| Irbesartan | Excretion | Kidney 20%, feces 65% | 1.00 | infobox |
| Irbesartan | Formula | C25H28N6O | 1.00 | infobox |
| Irbesartan | IUPHAR/BPS | 589 | 1.00 | infobox |
| Irbesartan | KEGG | D00523 Y | 1.00 | infobox |
| Irbesartan | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Irbesartan | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Irbesartan | Legal status | US: ℞-only | 1.00 | infobox |
| Irbesartan | Legal status | EU: Rx-only | 1.00 | infobox |
| Irbesartan | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Irbesartan | License data | US DailyMed: Irbesartan | 1.00 | infobox |
| Irbesartan | MedlinePlus | a698009 | 1.00 | infobox |
| Irbesartan | Metabolism | Liver (CYP2C9) | 1.00 | infobox |
| Irbesartan | Molar mass | 428.540 g·mol−1 | 1.00 | infobox |
| Irbesartan | Pregnancy category | AU: D | 1.00 | infobox |
| Irbesartan | Pronunciation | /ɜːrbəˈsɑːrtən/ | 1.00 | infobox |
| Irbesartan | Protein binding | ~90% | 1.00 | infobox |
| Irbesartan | PubChem CID | 3749 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.